August 2025

Pharma Courses
NIBMG Advertisement for Biotechnology or Life Sciences candidates
14 August 2025

NIBMG Advertisement for Biotechnology or Life Sciences candidates

Graduate Degree in Biotechnology or any Life Sciences subject from a recognized University or equivalent. Understanding the Molecular Mechanism in Ceramide Induced Pathological Activation of Nek7/Nlrp3-Inflammasome. 
14 August 2025
Applications are invited for Project Assistant at NIMHANS
Bachelor of Science (B.Sc) with biology as main subject, Bachelors in Engineering with biotechnology (MSc) with minimum 55% of total marks (equivalent grade) in Molecular biology, Genetics, Biochemistry, Biotechnology.
14 August 2025
NEIST Openings for Chemistry, Biotechnology, Microbiology, Bioinformatics candidates
M. Sc. in Chemistry, Biotechnology, Microbiology, Bioinformatics. Work experience in synthesis of nanomaterials, nanocomposites, membrane design etc.
14 August 2025
Applications are invited for Research Assistant in Bioinformatics at NCBS
Masters degree in the bioinformatics or relevant disciplines, with demonstrated interest and experience in bioinformatic analysis and a strong computational background.
14 August 2025
Macleods Pharma Walk in Drive for M.Pharm, B.Pharm, MSc in Production, QA, QC
M.Pharm, B.Pharm, M.Sc, B.Sc. Experience in Granulation, Compression, Coating, capsule fiiling, Liquid Manufacturing, packaging.
14 August 2025
Openings for B.Pharm, M.Pharm in DRA, Production Department at Gracure Pharma
Gracure Pharmaceutical Ltd. is a Delhi based pharmaceutical company, established in 1992 by Mr. A.S Bhargava with the vision of making world class affordable medicines.
14 August 2025
Walk in Drive for B.Pharm, BSc as Operator and Executive Roles at Eisai Pharmaceuticals
Having good experience and exposure in Dispensing. Granulation, Compression, Coating. Preference to Enteric & Sugar Coating, and Compression Kilian & Fette Machines, Packing CVC Blister Packing & Blister Cartonator.
14 August 2025
Apertura Gene Therapy Licenses Blood-Brain Barrier-Penetrant AAV Capsid to Multiple Partners Advancing Central Nervous System Treatments

Apertura Gene Therapy, a biotechnology company focused on innovative gene therapy solutions announced several licensing deals with Galibra Neuroscience and Emugen Therapeutics to utilize Apertura’s human transferrin receptor 1 capsid (TfR1 CapX) for their central nervous system (CNS) programs. A third venture-backed biotechnology company has entered into an Option Agreement with Apertura for multiple CNS indications.

14 August 2025
AAVantgarde Bio announces FDA Fast Track Designation for AAVB-039 for the Treatment of Stargardt Disease
AAVantgarde Bio a clinical-stage biotechnology company developing next-generation gene therapies for inherited retinal diseases, today announced that the U.S. Food and Drug Administration has granted Fast Track Designation for AAVB-039, the companys gene therapy program for Stargardt disease secondary to biallelic mutation in ABCA4
13 August 2025
CSIR Emeritus Scientist Scheme 2025 for B.Pharm, M.Pharm, MSc candidates
The minimum qualifications are BS 4 years programme, BPharm, MBBS, Integrated BS-MS, MSc, BE, BTech or equivalent degree, with 55% marks and passing of NET, GATE test.